Q: I don’t see a quick list of the current management beyond Goodman. Could you list? I want to fax my vote off today.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Portfolio analytics says I am low in healthcare so that means pretty much US companies. I already have 3.5% in Abbot but see you referring to Medtronic as attractive quite often. Since they are both in the medical device category, does this make buying MDT to similar of a purchase to ABT? Would I be better switching to MDT or look at something else in the sector. Some capital gains if I do switch.
Thanks for the great service.
Thanks for the great service.
Q: Hi all,
I had limited Healthcare exposure (only from small positions in VXUS and VGRO). Recently added Abbvie and Pfizer on price weakness. Combined these 2 equal about 5% of my Holdings.
3 questions:
1-Comments on ABBV latest quarter? (Seems good)
2-Good Entry point for these companies for a long term hold?
3-Do these 2 companies compliment each other well or should I consider adding another stock or ETF for more Healthcare exposure?
Thanks as always for the great service!
I had limited Healthcare exposure (only from small positions in VXUS and VGRO). Recently added Abbvie and Pfizer on price weakness. Combined these 2 equal about 5% of my Holdings.
3 questions:
1-Comments on ABBV latest quarter? (Seems good)
2-Good Entry point for these companies for a long term hold?
3-Do these 2 companies compliment each other well or should I consider adding another stock or ETF for more Healthcare exposure?
Thanks as always for the great service!
-
Knight Therapeutics Inc. (GUD $6.45)
-
Heroux-Devtek Inc. (HRX $32.48)
-
HLS Therapeutics Inc. (HLS $5.22)
Q: I've been a longtime holder of GUD but have become somewhat frustrated at the lack of growth. I'm wondering what your thoughts are about splitting my Knight holdings and placing them in HRX and HLS. Is there a decent risk/reward scenario here? Both companies are near 52 week highs but seem to be somewhat under reported.
Thank you for a fantastic service!
Mike
Thank you for a fantastic service!
Mike
-
Apple Inc. (AAPL $227.76)
-
Amazon.com Inc. (AMZN $228.84)
-
Alphabet Inc. (GOOG $206.72)
-
Intuitive Surgical Inc. (ISRG $476.16)
-
Walgreens Boots Alliance Inc. (WBA $12.07)
-
Abbott Laboratories (ABT $132.59)
Q: What are you're thoughts on WBA's earnings. Given the recent selloff would you still hold it for the long term or sell. I do not mind volatility. If it is a sell what US stock would you replace it with for growth. Thanks Chris
Q: Your thoughts on buying exe now?
Q: Where do you see GUD going over the next few months. Have a small position. Is it worthwhile to hold steady and see what happens or to exit. If Goodman stays at the helm, what should it mean for the stock?
Q: Do you have any thoughts on RVX at this point in its development? Its latest press release sounds promising
Cathy
Cathy
Q: Hi, got information package , it says after 5 years, Knight only has 0.05 % of the market. This does not seem right? Are they playing with the numbers here?
I will vote for the current management team, as I’am sure this is in your view the best course?
Is it time to rethink investing in this stock, considering the on going insider bickering.
This stock reminds me of Wy LAN 4to 6years ago that did not work out well. Your thoughts?
Thanks
I will vote for the current management team, as I’am sure this is in your view the best course?
Is it time to rethink investing in this stock, considering the on going insider bickering.
This stock reminds me of Wy LAN 4to 6years ago that did not work out well. Your thoughts?
Thanks
Q: Anything you can tell me about this small cap health care payment and solutions provider like management,growth,cash flow or any near term catalysts.....thank you
Q: Hey guys,
MDT gets lots of love on here but seems to be losing a bit of steam. The chart is concerning and it appears ready to test the 82.50 mark. Do you continue to like it and how far are you willing to tolerate what appears to be a downtrend? Hold with conviction or is there a point you throw in the towel?
MDT gets lots of love on here but seems to be losing a bit of steam. The chart is concerning and it appears ready to test the 82.50 mark. Do you continue to like it and how far are you willing to tolerate what appears to be a downtrend? Hold with conviction or is there a point you throw in the towel?
Q: Could you please give me a summary of this company's last financials. Is there more than just political worries effecting their stock price?
Q: Why is the stock holding at .05 when the restructuring set at .015?
Q: any idea why DR has taken a hit today?
thank you
thank you
Q: Well, this sort of thing is alarming. DR is down almost 5% with selling at noon exceeding the average daily numbers. The only news I see is the dividend announcement.
Who is selling? On what information does someone unload like this? How do I get such, presumably, useful information?
Who is selling? On what information does someone unload like this? How do I get such, presumably, useful information?
Q: ISRG reports today after market close. I seem to recall that they missed consensus in the previous quarter. I think these are factors in the recent market weakness.
Regards,
Jim
Regards,
Jim
Q: This US ETF was down significantly yesterday. Do you have any info why?
Thanks Dave
Thanks Dave
Q: I would like your comments on this ETF. Is it a good investment for a retired investor.
Thank you
Thank you
Q: can you shed light on the reasons why this stock dropped over 5% over yesterday and today? I didn't see any news from the FDA or news
on advances made by the competition. Is iit the sector in general? Is it a good time to buy?
Really appreciate your perspectives and common sense.
Thanks
on advances made by the competition. Is iit the sector in general? Is it a good time to buy?
Really appreciate your perspectives and common sense.
Thanks
Q: Considering the tone if the release this morning on Knight's Directors, I would take a wild guess it was commissioned by Jakobsohn.
Goodman put his pharmascience shares in a blind trust. This NR is no big deal...
Goodman put his pharmascience shares in a blind trust. This NR is no big deal...